Resmed RMD
NYSE RMD
$246.28 +0.78 (+0.32%)
As of: Oct 21, 2026 · 3:59 PM EDT

Resmed (RMD) Restructuring Costs (2015 - 2025)

Updated

Resmed's Restructuring Costs was $21.75 million in FY2026 (year ended Jun 30, 2026).

Analysis

Resmed (RMD) Restructuring Costs (2015 - 2025) Analysis & Trends

From FY2014 onward, Resmed has reported Restructuring Costs for 10 fiscal years.

  • Restructuring Costs shows a five-year compound annual growth rate of 20.2% (FY2021 to FY2026).
  • The FY2026 figure marks the lowest annual Restructuring Costs since FY2023.
  • Per Business Quant data, Restructuring Costs in earlier fiscal years was $64.23 million in FY2024 (+486.6%), $10.95 million in FY2023 (+476.3%) and $1.9 million in FY2022 (-78.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Resmed 35.85 Bn 29.92 Bn 861.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5.94 Mn
Sep 30, 2025 15.81 Mn
Dec 31, 2023 64.23 Mn
Jun 30, 2023 1.79 Mn
Dec 31, 2022 8.41 Mn
Jun 30, 2022 1.90 Mn
Dec 31, 2020 8.67 Mn
Jun 30, 2019 3.28 Mn
Dec 31, 2018 6.12 Mn
Jun 30, 2018 7.51 Mn
Mar 31, 2018 10.92 Mn
Mar 31, 2017 7.95 Mn
Dec 31, 2016 10.08 Mn
Dec 31, 2015 6.91 Mn
API Access

Resmed Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=RMD&period=max&api_key=YOUR_API_KEY